Understanding the QuantiFERON-TB Gold Plus Test The QuantiFERON-TB Gold Plus (QFT-Plus) is an interferon-gamma release assay (IGRA) blood test used to detect Mycobacterium tuberculosis infection. This distinction is not determined by the IGRA result alone but through a synthesis of clinical judgment, patient history, and further diagnostic testing to rule out pulmonary or extrapulmonary TB.
Understanding QuantiFERON TB Gold Plus Latent TB Indication and Abnormal Results
The test works by exposing a blood sample to antigens unique to the TB bacterium; if the person has been exposed, their white blood cells will release interferon-gamma, a measurable marker of infection. The biological basis of this reaction is the immune memory responding to specific TB antigens, confirming exposure rather than current illness.
It is designed to be a more specific alternative to the traditional tuberculin skin test (TST), as it is not influenced by prior BCG vaccination and is not subject to errors caused by observer bias. However, a positive result does not automatically mean the person has active, contagious tuberculosis disease.
Understanding QuantiFERON TB Gold Plus Latent TB Indication After an Abnormal Result
Healthcare providers evaluate factors like the patient's age, immune status, the likelihood of exposure to active TB, and potential side effects of the medication to determine if the preventive treatment is appropriate for the individual. What "Abnormal" Typically Signifies In the context of a QFT-Plus test, an "abnormal" result most commonly refers to a positive test outcome.
More About Quantiferon-tb gold plus abnormal
Looking at Quantiferon-tb gold plus abnormal from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on Quantiferon-tb gold plus abnormal can make the topic easier to follow by connecting earlier points with a few simple takeaways.
